Lauren Harshman MD, Co-director of Kidney Cancer Program Dana-Farber Cancer Institute/Harvard Medical School discusses Biologic Rational For Neoadjuvant OVER Adjuvant Approach with IO at the 13th European International Kidney Cancer Symposium 2018 in Prague.
Biologic Rational For Neoadjuvant OVER Adjuvant Approach with IO
